3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is increasingly attracting clinical focus due to initial evidence suggesting different physiological characteristics. Preliminary research https://www.pinterest.com/pin/1140888518124046392/